Acobiom’s business model is based on two main activities:
(1) developing and commercializing diagnostics and companion diagnostics (CDx), notably for personalized medicine applications;
(2) providing services in the fields (+)
Acobiom was founded by Didier Ritter and Dr David Piquemal under the name « Skuldtech », with the support of Pr Jacques Marti and Pr Therese Commes-Maerten, and their academic laboratory (+)
Senior Management Didier Ritter: Chief Executive Officer, MSc in Molecular Biology and MBA, Founder of Acobiom, President of the boards of Kyomed and the Biomeridies Cluster, President and founder of (+)
The scientific board of Acobiom is moving forward and will soon welcome Key Opinion Leader and personalities associated with Personalized Medicine, Translational Research and Omics BIG DATA.
Carlini F et al. Front Immunol. 2017 Jan 23;8:6. doi: 10.3389/fimmu.2017.00006.